Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Search Videos by Topic or Participant
Browse by Series:

Gastrointestinal Stromal Tumor Diagnosis

Insights From: Robert Hans Ingemar Andtbacka, MD, CM, Huntsman Cancer Institute ; Anthony P. Conley, MD, The University of Texas MD Anderson Cancer CenterSyma Iqbal, MD, UCS Norris Comprehensive Cancer Center and Hospital
Published: Friday, Oct 30, 2015


The clinical presentation that is typically observed with gastrointestinal stromal tumors (GISTs) is somewhat nonspecific, states Anthony P. Conley, MD. Patients may report symptoms related to anemia, such as fatigue and changes in skin color, usually in the chronic setting. GISTs can be detected through upper endoscopy or colonoscopy, notes Conley, but may escape detection because they tend to arise in the muscular layer rather than the epithelial portion of the gastrointestinal tract. Once GIST is suspected, it is important to conduct a biopsy to rule out other diseases, such as leiomyomas and leiomyosarcomas, comments Conley.

The majority of patients with GIST are asymptomatic, says Robert H. I. Andtbacka, MD, although they may present with abdominal discomfort and gastrointestinal bleeding. A GIST diagnosis is often discovered with CT scan of the abdomen, pelvis, and small bowel, explains Andtbacka. Colonoscopies also help confirm that the malignancy is not adenocarcinoma, which is more common in these locations than GIST, says Andtbacka.

Obtaining a core biopsy also allows for immunohistochemical staining for mast/stem cell growth factor receptor, also known as c-KIT (CD117), platelet derived growth factor receptor, and other receptors. Staining positive for these markers can also indicate a GIST diagnosis, as approximately 95% of GIST tumors express c-KIT.
Slider Left
Slider Right


The clinical presentation that is typically observed with gastrointestinal stromal tumors (GISTs) is somewhat nonspecific, states Anthony P. Conley, MD. Patients may report symptoms related to anemia, such as fatigue and changes in skin color, usually in the chronic setting. GISTs can be detected through upper endoscopy or colonoscopy, notes Conley, but may escape detection because they tend to arise in the muscular layer rather than the epithelial portion of the gastrointestinal tract. Once GIST is suspected, it is important to conduct a biopsy to rule out other diseases, such as leiomyomas and leiomyosarcomas, comments Conley.

The majority of patients with GIST are asymptomatic, says Robert H. I. Andtbacka, MD, although they may present with abdominal discomfort and gastrointestinal bleeding. A GIST diagnosis is often discovered with CT scan of the abdomen, pelvis, and small bowel, explains Andtbacka. Colonoscopies also help confirm that the malignancy is not adenocarcinoma, which is more common in these locations than GIST, says Andtbacka.

Obtaining a core biopsy also allows for immunohistochemical staining for mast/stem cell growth factor receptor, also known as c-KIT (CD117), platelet derived growth factor receptor, and other receptors. Staining positive for these markers can also indicate a GIST diagnosis, as approximately 95% of GIST tumors express c-KIT.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x